Mandating Exclusive Review of Individual Treatments (MERIT) Act
Summary
Mandating Exclusive Review of Individual Treatments (MERIT) Act This bill specifies that coverage determinations for drugs and biologics under Medicare must be made with respect to each drug or biologic, rather than with respect to a class of drugs or biologics.
Bill status
in committee
1 of 4 stages cleared
Introduction
Oct 2022
Committee Review
Floor Vote
President
Introduced Oct 4, 2022
Last action Oct 5, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
2
Oct 5, 2022
Committee
Referred to the Subcommittee on Health.
lower
Oct 4, 2022
Committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
Oct 4, 2022
Introduced
Introduced in House
lower
1 primary · 8 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Vern Buchanan
RRepublican
Co
A. Drew Ferguson IV
RRepublican
Co
Adrian Smith
RRepublican
Co
Brian K. Fitzpatrick
RRepublican
Co
John H. Rutherford
RRepublican
Co
Maria Elvira Salazar
RRepublican
Co
Mariannette Miller-Meeks
RRepublican
Co
Nanette Diaz Barragán
DDemocratic
Co
Neal P. Dunn
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 9127
Scope: US
Hi! I can help you understand HR 9127. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline